Author response for "Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: a randomized, double‐blind, placebo‐controlled trial (MIRAD trial)"
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽